logowsbdaily | Mon, 26 Sep 2022 03:58:39 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

InMed Pharmaceuticals Inc.
(INM)

InMed Pharmaceuticals Inc.
815 West Hastings Street
Suite 310
Vancouver, BC V6C 1B4
Canada
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based trea... Read More

Summary & Charts

Price$ 5.57-1.35 (-19.51%)
Day's Range$ 5.12 - 6.81 
Previous Close$ 6.92
Market Cap$ 7.86M USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqCM
IndustryBiotechnology
SectorHealthcare
Volume244.53K
Avg. Volume (20 day)2.87M
Rel. Volume (20 day)0.09
Rel. Volume (3 month)0.23
RatingA+Buy
DCFN/AStrong Buy
Debt/Equity45.76 %Neutral
ROE-0.05 %Strong Buy
ROA-0.09 %Strong Buy
P/E-288.53 %Neutral
P/B0.39 %Neutral
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Sep 23, 2022$ 6.49$ 6.81$ 5.12$ 5.57-1.35244,5340.090.23
Sep 22, 2022$ 7.00$ 8.25$ 6.72$ 6.92-0.18414,1230.140.39
Sep 21, 2022$ 7.26$ 7.39$ 6.92$ 7.10-0.35129,2050.040.12
Sep 20, 2022$ 7.73$ 8.88$ 7.45$ 7.45-0.351,115,4580.371.06
Sep 19, 2022$ 8.29$ 8.29$ 7.63$ 7.80-0.69237,4760.080.23
Sep 16, 2022$ 9.01$ 9.33$ 8.32$ 8.49-1.12213,6080.070.21
Sep 15, 2022$ 10.77$ 10.86$ 9.32$ 9.61-1.39462,1010.160.46
Sep 14, 2022$ 11.44$ 11.50$ 9.18$ 11.00-1.07683,6740.230.70
Sep 13, 2022$ 15.02$ 16.35$ 11.45$ 12.07-6.712,085,3400.712.182
Sep 12, 2022$ 15.00$ 19.50$ 13.78$ 18.78+7.7631,815,90711.2434.23
Sep 09, 2022$ 10.84$ 13.25$ 9.09$ 11.02+2.152,990,9962.396.291
Sep 08, 2022$ 9.35$ 11.16$ 7.79$ 8.87+0.07659,2390.601.51
Sep 07, 2022$ 11.40$ 12.30$ 7.53$ 8.80+8.451,027,7540.962.381
Sep 06, 2022$ 0.38$ 0.43$ 0.33$ 0.35+0.038,083,6007.8819.04
Sep 02, 2022$ 0.32$ 0.35$ 0.29$ 0.32+0.013,855,6006.1612.18
Sep 01, 2022$ 0.23$ 0.32$ 0.23$ 0.31+0.071,497,7003.425.63
Aug 31, 2022$ 0.26$ 0.27$ 0.24$ 0.24-0.02248,3000.681.00
Aug 30, 2022$ 0.25$ 0.27$ 0.25$ 0.26+0.02304,0000.851.22
Aug 29, 2022$ 0.26$ 0.28$ 0.24$ 0.24-0.02426,2001.231.72
Aug 26, 2022$ 0.27$ 0.28$ 0.25$ 0.26+0.01811,1002.473.32

News

The latest news about InMed Pharmaceuticals Inc. (INM).

Seeking Alpha | 2022-09-23 15:28:08
InMed Pharmaceuticals Inc. (NASDAQ:INM ) Q4 2022 Results Conference Call September 23, 2022 1:00 PM ET Company Participants Colin Clancy - VP, IR Eric Adams - President and CEO Michael Woudenberg - COO Brenda Edwards - Interim CFO Dr. Eric Hsu - SVP, Preclinical Research and Development Conference Call Participants Scott Henry - ROTH Capital Partners Raghuram Selvaraju - H.C. Wainwright Operator Good day.
GlobeNewsWire | 2022-09-19 18:00:00
VANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, will report financial results on Friday, September 23, 2022 for the fiscal year ended June 30, 2022.
InvestorPlace | 2022-09-12 13:59:34
The relief rally we've seen play out last week is once again in full focus on Monday. All major indices have moved higher today.
InvestorPlace | 2022-09-09 09:53:31
Source: gvictoria / Shutterstock.com InMed Pharmaceuticals (NASDAQ: INM ) stock is rocketing higher on Friday after the company revealed research and development (R&D) updates. According to the cannabis company, it's reevaluating its business to better focus on its core pharmaceutical efforts.
PennyStocks | 2022-09-02 06:00:00
Here's what you need to know about trading penny stocks on September 2nd The post Trending Penny Stocks For Your September Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Pulse2 | 2022-08-24 07:05:52
InMed Pharmaceuticals (INM) announced it will be consolidating all of its issued and outstanding share capital on the basis of 1 for 25 pre‐consolidation common shares of the company. These are the details.
Schaeffers Research | 2022-07-29 15:45:08
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2022-11-08BMO------0.8M----
2022-09-23BMO------0.8M1.1K-99.86%
2022-05-13BMO-6.25-6.25--310K310-99.9%
2022-02-14BMO-6-7.7529.16%120K----
2021-11-10BMO-8.75-6.2528.58%------
2021-09-24BMO-8.5-10.2520.58%------
2021-05-13BMO-6-10.2570.83%------
2021-02-11BMO-6-9.2554.16%------

Due Diligences

These posts should include more in-depth research by the poster about the specific company, sector or trade idea. Including any sources and citations.

Analysis of: InMed Pharmaceuticals (NASDAQ-CM: $INM)

Brief Overview, * Doing a bit of research into pharmaceutical companies, I found an interesting one. Being InMed Pharmaceuticals, based in Vancouver, Canada, they’re a global leader in development, manufacturing and commercialization of rare cannabinoids. With a subsidiary, Baymedica LLC, they focu... Read More

2 comments | 14 votes
(NASDAQ-CM: $INM) InMed Pharmaceuticals {DD}

Brief Overview, * Doing a bit of research into pharmaceutical companies, I found an interesting one. Being InMed Pharmaceuticals, based in Vancouver, Canada, they’re a global leader in development, manufacturing and commercialization of rare cannabinoids. With a subsidiary, Baymedica LLC, they focu... Read More

Top Discussions

These are the top discussions over the last 24-hours that mention the INM stock ticker symbol.


Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Tue, 14 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.